• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺罕见的假肌源性血管内皮瘤(PHE)/上皮样肉瘤样血管内皮瘤(ES-H),最初通过细针穿刺活检(FNAB)误诊为化生性癌,并复习文献。

A rare case of pseudomyogenic hemangioendothelioma (PHE)/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature.

机构信息

Department of Pathology, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, 106, Zhongshan Road II, Guangzhou, 510000, China.

出版信息

Diagn Pathol. 2019 Jul 17;14(1):79. doi: 10.1186/s13000-019-0857-6.

DOI:10.1186/s13000-019-0857-6
PMID:31311568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6635997/
Abstract

AIMS

Pseudomyogenic hemangioendothelioma (PHE)/epithelioid sarcoma-like hemangioendothelioma (ES-H) is a rare vascular tumor of intermediate malignancy that commonly occurs in soft tissue of distal extremities of young adults. PHE typically has a multifocal presentation and can involve several tissue planes, including the dermis, subcutis, muscle and bone.

METHODS AND RESULTS

We present here a unique case of PHE/ESH that arose in the breast as well as a review of the published literature. The initial biopsy was interpreted as a metaplastic carcinoma. However, complete resection largely revealed plump epithelioid cells, and a more spindled cell component was also noted. The cells displayed abundant eosinophilic cytoplasm and central vesicular nuclei arranged in loose fascicles, with a mild, mixed acute and chronic inflammatory infiltrate. Overall, linear membranous staining of CD31 and lack of CD34 expression were highly suggestive of PHE. At the same time, FOSB immunoreactivity was observed, which supported PHE/ESH instead of metaplastic carcinoma. The patient has not shown recurrence in the half year follow up after total mastectomy.

CONCLUSION

To our knowledge, this is the first report of breast involvement in this neoplasm. Recognition of its histopathological features and immunohistochemical reactivity will prevent misdiagnosis of breast lesions.

摘要

目的

假肌源性血管内皮瘤(PHE)/上皮样肉瘤样血管内皮瘤(ES-H)是一种罕见的中度恶性血管肿瘤,常见于年轻成人四肢远端的软组织中。PHE 通常呈多灶性表现,并可累及多个组织平面,包括真皮、皮下组织、肌肉和骨骼。

方法和结果

我们在此介绍一例发生在乳房的 PHE/ES-H 独特病例,并对已发表的文献进行了回顾。最初的活检被解释为化生性癌。然而,完全切除后主要显示出饱满的上皮样细胞,也注意到了更梭形的细胞成分。这些细胞显示出丰富的嗜酸性细胞质和中央泡状核,呈松散的束状排列,伴有轻度混合性急性和慢性炎症浸润。总体而言,CD31 的线性膜染色和缺乏 CD34 表达强烈提示为 PHE。同时,观察到 FOSB 免疫反应性,支持 PHE/ES-H 而不是化生性癌。患者在全乳切除术后半年的随访中没有出现复发。

结论

据我们所知,这是首例该肿瘤累及乳房的报告。认识其组织病理学特征和免疫组织化学反应将有助于防止对乳腺病变的误诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b7/6635997/ff59ab5e2a62/13000_2019_857_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b7/6635997/41ab2e1a8e6b/13000_2019_857_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b7/6635997/44a347d1f426/13000_2019_857_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b7/6635997/ff59ab5e2a62/13000_2019_857_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b7/6635997/41ab2e1a8e6b/13000_2019_857_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b7/6635997/44a347d1f426/13000_2019_857_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b7/6635997/ff59ab5e2a62/13000_2019_857_Fig3_HTML.jpg

相似文献

1
A rare case of pseudomyogenic hemangioendothelioma (PHE)/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature.乳腺罕见的假肌源性血管内皮瘤(PHE)/上皮样肉瘤样血管内皮瘤(ES-H),最初通过细针穿刺活检(FNAB)误诊为化生性癌,并复习文献。
Diagn Pathol. 2019 Jul 17;14(1):79. doi: 10.1186/s13000-019-0857-6.
2
Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.假肌源性血管内皮瘤:一种具有惰性行为的独特、常为多中心肿瘤。
Am J Surg Pathol. 2011 Feb;35(2):190-201. doi: 10.1097/PAS.0b013e3181ff0901.
3
The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature.假肌源性血管内皮瘤的临床病理谱:附加系列报告并文献复习。
Virchows Arch. 2020 Aug;477(2):231-240. doi: 10.1007/s00428-020-02753-4. Epub 2020 Jan 24.
4
FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.FOSB是假性肌源性血管内皮瘤的一种有用诊断标志物。
Am J Surg Pathol. 2017 May;41(5):596-606. doi: 10.1097/PAS.0000000000000795.
5
Pseudomyogenic Hemangioendothelioma: Case Report and Review of the Literature.假肌源性血管内皮瘤:病例报告及文献复习
Am J Dermatopathol. 2018 Aug;40(8):597-601. doi: 10.1097/DAD.0000000000001104.
6
Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.FOSB免疫组化在假性肌源性血管内皮瘤及其组织学模仿物中的诊断效用
Diagn Pathol. 2016 Aug 11;11(1):75. doi: 10.1186/s13000-016-0530-2.
7
A rare case of multifocal pseudomyogenic hemangioendothelioma, involving soft tissues and bone, misdiagnosed as a rhabdomyosarcoma: Diagnostic and treatment implications.一例罕见的多灶性假肌源性血管内皮瘤,累及软组织和骨骼,误诊为横纹肌肉瘤:诊断及治疗意义
Indian J Pathol Microbiol. 2016 Jul-Sep;59(3):382-5. doi: 10.4103/0377-4929.188144.
8
Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue-a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study.皮肤、骨和软组织的假肌源性血管内皮瘤:一项临床病理、免疫组织化学和荧光原位杂交研究。
Hum Pathol. 2018 Jan;71:126-134. doi: 10.1016/j.humpath.2017.10.023. Epub 2017 Nov 2.
9
Epithelioid sarcoma-like (pseudomyogenic) hemangioendothelioma, clinically mimicking dermatofibroma, diagnosed by skin biopsy in a 30-year-old man.
J Cutan Pathol. 2013 Oct;40(10):909-13. doi: 10.1111/cup.12196. Epub 2013 Aug 23.
10
A case of pseudomyogenic hemangioendothelioma misdiagnosed as low-grade malignant fibrous histiocytoma and review of literature.误诊为低度恶性纤维组织细胞瘤的假肌源性血管内皮瘤 1 例并文献复习
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Mar 28;47(3):390-395. doi: 10.11817/j.issn.1672-7347.2022.210177.

引用本文的文献

1
Beyond the rare: a case of pseudomyogenic hemangioendothelioma treated sequentially with everolimus, denosumab, and pazopanib.超越罕见病例:一例先后接受依维莫司、地诺单抗和帕唑帕尼治疗的假性肌源性血管内皮瘤病例。
Einstein (Sao Paulo). 2024 Dec 16;22:eRC1107. doi: 10.31744/einstein_journal/2024RC1107. eCollection 2024.
2
Clinicopathological study of pseudomyogenic hemangioendothelioma.假性肌源性血管内皮瘤的临床病理研究。
Diagn Pathol. 2023 Feb 20;18(1):25. doi: 10.1186/s13000-023-01309-9.
3
Pazopanib as Treatment Option for Pseudomyogenic Hemangioendothelioma: A Case Report.

本文引用的文献

1
Pseudomyogenic Hemangioendothelioma.假肌源性血管内皮瘤。
Arch Pathol Lab Med. 2019 Jun;143(6):763-767. doi: 10.5858/arpa.2017-0430-RS. Epub 2018 Dec 21.
2
The management of pseudomyogenic hemangioendothelioma of the foot: A case report and review of the literature.足部假肌源性血管内皮瘤的治疗:病例报告及文献复习。
Dermatol Ther. 2018 Nov;31(6):e12725. doi: 10.1111/dth.12725. Epub 2018 Sep 21.
3
Diagnostic Immunohistochemistry for Soft Tissue and Bone Tumors: An Update.软组织和骨肿瘤的诊断免疫组织化学:更新。
帕唑帕尼作为假性肌源性血管内皮瘤的治疗选择:一例报告
Cureus. 2022 May 23;14(5):e25250. doi: 10.7759/cureus.25250. eCollection 2022 May.
4
Oral Pseudomyogenic Hemangioendothelioma: Case Report and Review of the Literature.口腔假肌源性血管内皮瘤:病例报告及文献复习。
Head Neck Pathol. 2020 Dec;14(4):1134-1138. doi: 10.1007/s12105-020-01137-z. Epub 2020 Feb 3.
5
The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature.假肌源性血管内皮瘤的临床病理谱:附加系列报告并文献复习。
Virchows Arch. 2020 Aug;477(2):231-240. doi: 10.1007/s00428-020-02753-4. Epub 2020 Jan 24.
Adv Anat Pathol. 2018 Nov;25(6):400-412. doi: 10.1097/PAP.0000000000000204.
4
Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma.替拉替尼是一种有效的假肌源性血管内皮瘤的靶向治疗药物。
Clin Cancer Res. 2018 Jun 1;24(11):2678-2687. doi: 10.1158/1078-0432.CCR-17-3512. Epub 2018 Mar 6.
5
Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue-a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study.皮肤、骨和软组织的假肌源性血管内皮瘤:一项临床病理、免疫组织化学和荧光原位杂交研究。
Hum Pathol. 2018 Jan;71:126-134. doi: 10.1016/j.humpath.2017.10.023. Epub 2017 Nov 2.
6
Cutaneous pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma FOSB immunohistochemistry demonstrating the SERPINE1-FOSB fusion gene.皮肤假性肌源性(上皮样肉瘤样)血管内皮瘤FOSB免疫组化显示SERPINE1-FOSB融合基因。
J Eur Acad Dermatol Venereol. 2017 Dec;31(12):e550-e552. doi: 10.1111/jdv.14417. Epub 2017 Jul 12.
7
Everolimus for Treatment of Pseudomyogenic Hemangioendothelioma.依维莫司治疗假性肌源性血管内皮瘤
J Pediatr Hematol Oncol. 2017 Aug;39(6):e328-e331. doi: 10.1097/MPH.0000000000000778.
8
FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.FOSB是假性肌源性血管内皮瘤的一种有用诊断标志物。
Am J Surg Pathol. 2017 May;41(5):596-606. doi: 10.1097/PAS.0000000000000795.
9
Pseudomyogenic Hemangioendothelioma: A Vascular Tumor Previously Undescribed in the Oral Cavity.假肌源性血管内皮瘤:一种口腔内此前未被描述过的血管肿瘤。
Head Neck Pathol. 2017 Dec;11(4):525-530. doi: 10.1007/s12105-016-0770-1. Epub 2016 Nov 22.
10
Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.FOSB免疫组化在假性肌源性血管内皮瘤及其组织学模仿物中的诊断效用
Diagn Pathol. 2016 Aug 11;11(1):75. doi: 10.1186/s13000-016-0530-2.